Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
Global health trends greatly impact cardiovascular needle sales. As cardiovascular problems develop worldwide, open-heart and vascular procedures need more cardiovascular instruments.
Ageing populations influence heart and vascular needle sales, a key market factor. The number of persons over 65 and with cardiovascular illnesses is rising. Due to community changes, more cardiac treatments are required, increasing need for specialist instruments.
Improved medical technology drives cardiovascular needle market development. New needle design, materials, and production procedures have improved cardiovascular therapy accuracy and safety. Thus, physicians and nurses are increasingly employing improved needle technology.
Chronic illnesses like diabetes and obesity generate heart difficulties that can only be treated by angioplasty and bypass. Circulatory needles, particularly those for difficult operations, are needed more as more individuals develop these health issues.
Healthcare facilities in various nations impact cardiovascular surgery availability and acceptability. Countries with strong healthcare systems require more circulatory needles. Due to their advanced medical facilities and experienced healthcare personnel.
Circulatory needle sales are affected by strict healthcare restrictions. Manufacturers must obey regulations. These regulations affect product development, approval, and market operation.
Rapidly increasing healthcare systems in emerging nations are driving cardiovascular instrument sales. More people in these regions know about arterial medicines, have more money, and can receive medical care more readily.
Circulatory needle manufacturing is competitive due to the large number of producers and sellers. Price strategy, product quality, and distribution may affect market share and profitability in this industry.
Safety and less-invasive therapies are priorities for patients. That impacts cardiovascular needle sales. Minimally invasive surgery technologies that prioritize patient safety are becoming more relevant. This trend reflects shifting health care preferences.
Payment regulations and insurance benefits impact what healthcare workers purchase. How cheap artery needles are impacts market trends and device acceptance.
How stable the economy is and how much the dollar moves may effect the circulatory needle market. Healthcare providers may not have enough money to buy cardiovascular instruments during economic downturns.
Research & development in the healthcare business improves cardiovascular needle technology. R&D expenditures drive new product creation by addressing market gaps and molding the future.
Cardiovascular Needle Market Highlights:
Cardiovascular Needle Market Overview
The cardiovascular needle market size is expected to reach USD 146.9 million by 2030 at 6.2% CAGR during the forecast period 2022-2030. Cardiovascular needles are used as a part of various heart and vascular mediations to close the surgical wound. Various surgeries such as cardiovascular surgeries, open heart surgery, cardiac valve procedures, heart transplant, coronary artery bypass graft surgery, and many more surgeries need surgical needles. Rising number of a patient having cardiovascular disease, diabetes, obesity and increasing aging population is driving the market.
According to the World Health Organization (WHO), in 2015, around 17.7 million people died from cardiovascular diseases, which represents 31% of all global deaths. Of these deaths, around 7.4 million were due to coronary heart disease and 6.7 million were due to stroke. According to the World Health Organization (WHO) in 2015, around 1.6 million deaths were directly caused by diabetes and in 2014, 8.5% of adults aged 18 years and older had diabetes. Thus, rising prevalence of chronic diseases is majorly driving the global cardiovascular market.
Various factors are adding fuel to the growth of the global market, such as unhealthy diet, low physical activities, etc. According to a research, smoking increases the possibility of diabetes; more than 60% of the global population smokes, this has increased the risk of diabetes and contributed to the growth of the market.
Moreover, advancing technology in the medical devices is adding fuel to the growth of the market. Furthermore, increasing government support in the developing countries drive the cardiovascular needle market growth.
However, increasing use of surgical staples instead of needles and suture can deter the demand for cardiovascular needles.
Cardiovascular Needle Market Segmentations
The global cardiovascular needle market is segmented on the basis of types, by application, by usage, and by the end user.
On the basis of the type, it is segmented into round bodied needles and cutting needles. Furthermore, round-bodied needles segmented into taper point needles and blunt point needles. Also, cutting needles segmented into conventional cutting needles and reverse cutting needles. Â
On the basis of the application, it is segmented into open heart surgery, cardiac valve procedures, coronary artery bypass graft surgery, heart transplant, and others. Â
On the basis of the usage, it is segmented into single use and multiple uses.
On the basis of the end user, it is segmented into hospitals, clinics, ambulatory surgical centers, and others.
Cardiovascular Needle Market Regional Analysis
The Americas dominate the global cardiovascular needle market owing to the rising prevalence of diabetes, obesity, and cardiovascular diseases. Furthermore increasing government support for research & development have fuelled the growth of the market in this region. According to the American Heart Association, in 2017, cardiovascular disease listed as the underlying cause of death which is likely to account for nearly 801,000 deaths in the US by the end of this year. It further estimated that about 2,200 Americans die of cardiovascular disease each day.
Europe holds the second position in the global market owing to the presence of major players. Although companies within this region are also involved in export to the developing countries which leads the market of Europe.
The Asia Pacific is the fastest growing market owing to the high presence of a patient with cardiovascular disease. Furthermore, the government of this region is looking forward to better the quality of needles, which increases the demand for cardiovascular needle market in this region.
On the other hand, in the Middle East and Africa hold the least market due to low research and development activities and poor healthcare infrastructure.
Cardiovascular Needle Market Key Players
Some of the key the players in the cardiovascular needles market are Becton, Dickinson, and Company (US), B. Braun Melsungen AG (Germany), Sheffield Ltd. (UK), CP Medical, Inc. (the US), Ethicon Inc. (US), KLS Martin Group (US), Sklar Surgical Instruments (US), Rumex International Corporation Ltd. (US), Scanlan International Inc. (US), Teleflex Incorporated (US), Medline Industries, Inc. (US), Surgins surgical Ltd. (UK), Surtex Instruments Ltd. (UK), Cardivon Surgical Inc. (China), Symmetry Surgical Inc. (US), Delacroix-Chevalier (France), Wexler Surgical (US), Quality Needles Pvt. Ltd. (India), FSSB surgical needles GmbH (Germany)
Intended Audience
- Cardiovascular needle manufacturers
- Cardiovascular needle suppliers
- Research and Development (R&D) Companies
- Government Research Laboratories
- Independent Research Laboratories
- Government and Independent Regulatory Authorities
- Market Research and Consulting Service Providers
- Medical Research Laboratories
- Academic Medical Institutes and Universities
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
